{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:44:02Z","timestamp":1795128242681,"version":"4.10.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["GR-2019-12368506"],"award-info":[{"award-number":["GR-2019-12368506"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11886-022-01680-x","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T02:02:27Z","timestamp":1645668147000},"page":"597-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-5257","authenticated-orcid":false,"given":"Enrico","family":"Ammirati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Buono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ciabatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"1680_CR1","unstructured":"\u2022 Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis. Circulation. 2018;138:1088\u201399. One of the largest multicenter clinical registry on acute myocarditis describing the outcome of these patiens."},{"key":"1680_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Tschope C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18:169\u201393. Probably the current most influential review on myocarditis.","DOI":"10.1038\/s41569-020-00435-x"},{"key":"1680_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13:e007405. A practical expert consensus document to guide diagnosis and treatment of myocarditis.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405"},{"key":"1680_CR5","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","volume":"71","author":"SS Mahmood","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71:1755\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41467-021-27631-8","volume":"13","author":"LS Nguyen","year":"2022","unstructured":"Nguyen LS, Cooper LT, Kerneis M, Funck-Brentano C, Silvain J, Brechot N, et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022;13:25.","journal-title":"Nat Commun"},{"key":"1680_CR7","doi-asserted-by":"crossref","unstructured":"\u2022 Poller W, Haas J, Klingel K, Kuhnisch J, Gast M, Kaya Z, et al. Familial recurrent myocarditis triggered by exercise in patients with a truncating variant of the desmoplakin gene. J Am Heart Assoc. 2020:e015289. A case report of great interest that describes in details acute myocarditis associated with DSP truncating variant.","DOI":"10.1161\/JAHA.119.015289"},{"key":"1680_CR8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/ehf2.12686","volume":"7","author":"N Piriou","year":"2020","unstructured":"Piriou N, Marteau L, Kyndt F, Serfaty JM, Toquet C, Le Gloan L, et al. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies. ESC Heart Fail. 2020;7:1520\u201333.","journal-title":"ESC Heart Fail"},{"key":"1680_CR9","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2020.04.048","volume":"75","author":"J Artico","year":"2020","unstructured":"Artico J, Merlo M, Delcaro G, Cannata A, Gentile P, De Angelis G, et al. Lymphocytic myocarditis: a genetically predisposed disease? J Am Coll Cardiol. 2020;75:3098\u2013100.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11886-018-1054-z","volume":"20","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Veronese G, Cipriani M, Moroni F, Garascia A, Brambatti M, et al. Acute and fulminant myocarditis: a pragmatic clinical approach to diagnosis and treatment. Curr Cardiol Rep. 2018;20:114.","journal-title":"Curr Cardiol Rep"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jcmg.2013.10.011","volume":"7","author":"M Francone","year":"2014","unstructured":"Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging. 2014;7:254\u201363.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1680_CR13","first-page":"5","volume":"14","author":"IA Bowman","year":"1987","unstructured":"Bowman IA. Jean-Baptiste Senac and his treatise on the heart. Tex Heart Inst J. 1987;14:5\u201311.","journal-title":"Tex Heart Inst J"},{"key":"1680_CR14","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636\u201348.","journal-title":"Eur Heart J"},{"key":"1680_CR15","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Seferovic PM, Tsutsui H, McNamara DM, Ristic AD, Basso C, Bozkurt B, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021;23:854\u201371. A new consensus document on indication to EMB.","DOI":"10.1002\/ejhf.2190"},{"key":"1680_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0046-8177(87)80363-5","volume":"18","author":"HT Aretz","year":"1987","unstructured":"Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18:619\u201324.","journal-title":"Hum Pathol"},{"key":"1680_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1536\/ihj.3.537","volume":"3","author":"S Sakakibara","year":"1962","unstructured":"Sakakibara S, Konno S. Endomyocardial biopsy. Jpn Heart J. 1962;3:537\u201343.","journal-title":"Jpn Heart J"},{"key":"1680_CR18","doi-asserted-by":"crossref","unstructured":"\u2022 Francis R, Lewis C. Myocardial biopsy: techniques and indications. Heart. 2018;104:950\u20138. A well-written review on why and how to perform an EMB.","DOI":"10.1136\/heartjnl-2017-311382"},{"key":"1680_CR19","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCULATIONAHA.107.743427","volume":"118","author":"M Holzmann","year":"2008","unstructured":"Holzmann M, Nicko A, Kuhl U, Noutsias M, Poller W, Hoffmann W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation. 2008;118:1722\u20138.","journal-title":"Circulation"},{"key":"1680_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cardfail.2018.03.013","volume":"24","author":"A Elbadawi","year":"2018","unstructured":"Elbadawi A, Elgendy IY, Ha LD, Mentias A, Ogunbayo GO, Tahir MW, et al. National trends and outcomes of endomyocardial biopsy for patients with myocarditis: from the National Inpatient Sample Database. J Card Fail. 2018;24:337\u201341.","journal-title":"J Card Fail"},{"issue":"121","key":"1680_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.amjcard.2017.10.021","volume":"2018","author":"V Singh","year":"2018","unstructured":"\u2022 Singh V, Mendirichaga R, Savani GT, Rodriguez A, Blumer V, Elmariah S, et al. Comparison of utilization trends, indications, and complications of endomyocardial biopsy in native versus donor hearts (from the Nationwide Inpatient Sample 2002 to 2014). Am J Cardiol. 2018;2018(121):356\u201363. Study showing the real-world indication to EMB and its complications.","journal-title":"Am J Cardiol"},{"key":"1680_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jacc.2019.05.026","volume":"74","author":"JJ Moslehi","year":"2019","unstructured":"Moslehi JJ, Brinkley DM, Meijers WC. Fulminant myocarditis: evolving diagnosis, evolving biology, evolving prognosis. J Am Coll Cardiol. 2019;74:312\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/HCO.0000000000000515","volume":"33","author":"S Van Linthout","year":"2018","unstructured":"Van Linthout S, Tschope C. Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy. Curr Opin Cardiol. 2018;33:325\u201333.","journal-title":"Curr Opin Cardiol"},{"key":"1680_CR24","doi-asserted-by":"crossref","unstructured":"\u2022 van der Boon RMA, den Dekker WK, Meuwese CL, Lorusso R, von der Thusen JH, Constantinescu AC, et al. Safety of endomyocardial biopsy in new-onset acute heart failure requiring veno-arterial extracorporeal membrane oxygenation. Circ Heart Fail. 2021;14:e008387. Original article on the risk and potential benefit of EMB in patients with cardiogenic shock supported by VA-ECMO.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008387"},{"key":"1680_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0735-1097(89)90465-8","volume":"14","author":"LH Chow","year":"1989","unstructured":"Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol. 1989;14:915\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0025-6196(12)61286-5","volume":"64","author":"AJ Hauck","year":"1989","unstructured":"Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989;64:1235\u201345.","journal-title":"Mayo Clin Proc"},{"key":"1680_CR27","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/eurheartj\/ehp328","volume":"30","author":"H Baccouche","year":"2009","unstructured":"Baccouche H, Mahrholdt H, Meinhardt G, Merher R, Voehringer M, Hill S, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J. 2009;30:2869\u201379.","journal-title":"Eur Heart J"},{"key":"1680_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tcm.2020.05.008","volume":"31","author":"E Ammirati","year":"2021","unstructured":"Ammirati E, Veronese G, Bottiroli M, Wang DW, Cipriani M, Garascia A, et al. Update on acute myocarditis. Trends Cardiovasc Med. 2021;31:370\u20139.","journal-title":"Trends Cardiovasc Med"},{"key":"1680_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","volume":"136","author":"E Ammirati","year":"2017","unstructured":"Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation. 2017;136:529\u201345.","journal-title":"Circulation"},{"key":"1680_CR30","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020:CIR0000000000000745. Recent American Scientific Statement on management of patients with fulminant myocarditis.","DOI":"10.1161\/CIR.0000000000000745"},{"key":"1680_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijcard.2020.10.063","volume":"324","author":"G Veronese","year":"2021","unstructured":"Veronese G, Ammirati E, Chen C, Klingel K, Suzuki M, Okumura T, et al. Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. Int J Cardiol. 2021;324:131\u20138.","journal-title":"Int J Cardiol"},{"key":"1680_CR32","first-page":"e579","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134:e579\u2013646.","journal-title":"Circulation"},{"key":"1680_CR33","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bennett MK, Gilotra NA, Harrington C, Rao S, Dunn JM, Freitag TB, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000\u20132009. Circ Heart Fail. 2013;6:676\u201384. A study that evaluates the role and the diagnostic yield of EMB in patients with unexplained heart failure.","DOI":"10.1161\/CIRCHEARTFAILURE.112.000087"},{"key":"1680_CR34","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","volume":"91","author":"G Sinagra","year":"2016","unstructured":"Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, et al. Myocarditis in clinical practice. Mayo Clin Proc. 2016;91:1256\u201366.","journal-title":"Mayo Clin Proc"},{"key":"1680_CR35","first-page":"180","volume":"15","author":"A Shauer","year":"2013","unstructured":"Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R, et al. Acute viral myocarditis: current concepts in diagnosis and treatment. MAJ. 2013;15:180\u20135.","journal-title":"MAJ"},{"key":"1680_CR36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1253\/circj.CJ-88-0008","volume":"75","author":"Group JCSJW","year":"2011","unstructured":"Group JCSJW. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75:734\u201343.","journal-title":"Circ J"},{"key":"1680_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12471-013-0499-3","volume":"22","author":"MR Hazebroek","year":"2014","unstructured":"Hazebroek MR, Everaerts K, Heymans S. Diagnostic approach of myocarditis: strike the golden mean. Neth Heart J. 2014;22:80\u20134.","journal-title":"Neth Heart J"},{"key":"1680_CR38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","volume":"5","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:819\u201324.","journal-title":"JAMA Cardiol"},{"key":"1680_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","volume":"144","author":"KF Larson","year":"2021","unstructured":"Larson KF, Ammirati E, Adler ED, Cooper LT, Hong KN, Saponara G, et al. Myocarditis after BNT162b2 and mRNA-1273 Vaccination. Circulation. 2021;144:506\u20138.","journal-title":"Circulation"},{"key":"1680_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2021.08.018","volume":"340","author":"A Abbate","year":"2021","unstructured":"Abbate A, Gavin J, Madanchi N, Kim C, Shah PR, Klein K, et al. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol. 2021;340:119\u201321.","journal-title":"Int J Cardiol"},{"key":"1680_CR41","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper Jr","year":"2009","unstructured":"Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526\u201338.","journal-title":"N Engl J Med"},{"key":"1680_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJM198504043121404","volume":"312","author":"GW Dec Jr","year":"1985","unstructured":"Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885\u201390.","journal-title":"N Engl J Med"},{"key":"1680_CR43","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","volume":"50","author":"LT Cooper","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007;50:1914\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0735-1097(89)90466-X","volume":"14","author":"ME Billingham","year":"1989","unstructured":"Billingham ME. Acute myocarditis: is sampling error a contraindication for diagnostic biopsies? J Am Coll Cardiol. 1989;14:921\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/oxfordjournals.eurheartj.a061281","volume":"3","author":"U Baandrup","year":"1982","unstructured":"Baandrup U, Florio RA, Olsen EG. Do endomyocardial biopsies represent the morphology of the rest of the myocardium? A quantitative light microscopic study of single v. multiple biopsies with the King\u2019s bioptome. Eur Heart J. 1982;3:171\u20138.","journal-title":"Eur Heart J"},{"key":"1680_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","volume":"21","author":"O Leone","year":"2012","unstructured":"Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2012;21:245\u201374.","journal-title":"Cardiovasc Pathol"},{"key":"1680_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jacc.2008.11.017","volume":"53","author":"M Pieroni","year":"2009","unstructured":"Pieroni M, Dello Russo A, Marzo F, Pelargonio G, Casella M, Bellocci F, et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol. 2009;53:681\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR48","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/pace.14014","volume":"43","author":"M Pieroni","year":"2020","unstructured":"Pieroni M, Notarstefano P, Ciabatti M, Nesti M, Martinese L, Liistro F, et al. Electroanatomic mapping-guided endomyocardial biopsy in patients with apparently idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol. 2020;43:1028\u201338.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1680_CR49","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.120.046900","volume":"142","author":"M Casella","year":"2020","unstructured":"Casella M, Dello Russo A, Bergonti M, Catto V, Conte E, Sommariva E, et al. Diagnostic yield of electroanatomic voltage mapping in guiding endomyocardial biopsies. Circulation. 2020;142:1249\u201360.","journal-title":"Circulation"},{"key":"1680_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12968-017-0357-3","volume":"19","author":"C Unterberg-Buchwald","year":"2017","unstructured":"Unterberg-Buchwald C, Ritter CO, Reupke V, Wilke RN, Stadelmann C, Steinmetz M, et al. Targeted endomyocardial biopsy guided by real-time cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19:45.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1680_CR51","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.hrthm.2011.07.021","volume":"8","author":"A Dello Russo","year":"2011","unstructured":"Dello Russo A, Pieroni M, Santangeli P, Bartoletti S, Casella M, Pelargonio G, et al. Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: role of cardiac electroanatomical mapping and biopsy. Heart Rhythm. 2011;8:1915\u201322.","journal-title":"Heart Rhythm"},{"key":"1680_CR52","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","volume":"72","author":"M Pieroni","year":"2018","unstructured":"Pieroni M, Notarstefano P, Oliva A, Campuzano O, Santangeli P, Coll M, et al. Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome. J Am Coll Cardiol. 2018;72:2747\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jacep.2017.09.175","volume":"4","author":"D Muser","year":"2018","unstructured":"Muser D, Santangeli P, Liang JJ, Castro SA, Magnani S, Hayashi T, et al. Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation. JACC Clin Electrophysiol. 2018;4:291\u2013303.","journal-title":"JACC Clin Electrophysiol"},{"key":"1680_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10840-018-0410-7","volume":"53","author":"VR Vaidya","year":"2018","unstructured":"Vaidya VR, Abudan AA, Vasudevan K, Shantha G, Cooper LT, Kapa S, et al. The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review. J Interv Card Electrophysiol. 2018;53:63\u201371.","journal-title":"J Interv Card Electrophysiol"},{"key":"1680_CR55","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.117.030834","volume":"137","author":"N Frey","year":"2018","unstructured":"Frey N, Meder B, Katus HA. Left ventricular biopsy in the diagnosis of myocardial diseases. Circulation. 2018;137:993\u20135.","journal-title":"Circulation"},{"key":"1680_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13006","author":"S Gobel","year":"2020","unstructured":"Gobel S, Schwuchow-Thonke S, Jansen T, Karbach S, Emrich T, Gori T, et al. Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy. ESC Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ehf2.13006.","journal-title":"ESC Heart Fail."},{"key":"1680_CR57","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","volume":"122","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900\u20139.","journal-title":"Circulation"},{"key":"1680_CR58","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/CIRCULATIONAHA.13.001414","volume":"128","author":"C Chimenti","year":"2013","unstructured":"Chimenti C, Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation. 2013;128:1531\u201341.","journal-title":"Circulation"},{"key":"1680_CR59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2459\/JCM.0000000000001162","volume":"22","author":"G Peretto","year":"2021","unstructured":"Peretto G, Cappelletti AM, Spoladore R, Slavich M, Rizzo S, Palmisano A, et al. Right ventricular endomyocardial biopsy in patients with cardiac magnetic resonance showing left ventricular myocarditis. J Cardiovasc Med (Hagerstown). 2021;22:560\u20136.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1680_CR60","unstructured":"\u2022\u2022 Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74:299\u2013311. Large international registry that assess the outcome and predictos of prognosis in patients with histologically proven fulminant myocarditis."},{"key":"1680_CR61","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","volume":"70","author":"M Brambatti","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017;70:2363\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR62","doi-asserted-by":"crossref","unstructured":"Cooper LT, Jr., Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997;336:1860\u20136.","DOI":"10.1056\/NEJM199706263362603"},{"key":"1680_CR63","first-page":"2663","volume":"38","author":"DH Birnie","year":"2017","unstructured":"Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J. 2017;38:2663\u201370.","journal-title":"Eur Heart J"},{"key":"1680_CR64","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68:411\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261","volume":"6","author":"R Kandolin","year":"2013","unstructured":"Kandolin R, Lehtonen J, Salmenkivi K, Raisanen-Sokolowski A, Lommi J, Kupari M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail. 2013;6:15\u201322.","journal-title":"Circ Heart Fail"},{"key":"1680_CR66","first-page":"764","volume":"115","author":"AP Burke","year":"1991","unstructured":"Burke AP, Saenger J, Mullick F, Virmani R. Hypersensitivity myocarditis. Arch Pathol Lab Med. 1991;115:764\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"1680_CR67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","volume":"113","author":"KL Baughman","year":"2006","unstructured":"Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593\u20135.","journal-title":"Circulation"},{"key":"1680_CR68","first-page":"917","volume":"109","author":"J Linder","year":"1985","unstructured":"Linder J, Cassling RS, Rogler WC, Wilson JE, Markin RS, Sears TD, et al. Immunohistochemical characterization of lymphocytes in uninflamed ventricular myocardium. Implications for myocarditis. Arch Pathol Lab Med. 1985;109:917\u201320.","journal-title":"Arch Pathol Lab Med"},{"key":"1680_CR69","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/01.CIR.99.7.889","volume":"99","author":"M Pauschinger","year":"1999","unstructured":"Pauschinger M, Phan MD, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation. 1999;99:889\u201395.","journal-title":"Circulation"},{"key":"1680_CR70","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/ejhf.1738","volume":"22","author":"G Veronese","year":"2020","unstructured":"Veronese G, Ammirati E, Brambatti M, Merlo M, Cipriani M, Potena L, et al. Viral genome search in myocardium of patients with fulminant myocarditis. Eur J Heart Fail. 2020;22:1277\u201380.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR71","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ejhf.2247","volume":"7","author":"E Ammirati","year":"2021","unstructured":"Ammirati E, Varrenti M, Veronese G, Fanti D, Nava A, Cipriani M, et al. Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab. Eur J Heart Fail. 2021;7:1242\u20135.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR72","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/ejhf.665","volume":"18","author":"J Verdonschot","year":"2016","unstructured":"Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430\u201341.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR73","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12024-014-9570-7","volume":"10","author":"TS Nielsen","year":"2014","unstructured":"Nielsen TS, Hansen J, Nielsen LP, Baandrup UT, Banner J. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts. Forensic Sci Med Pathol. 2014;10:344\u201350.","journal-title":"Forensic Sci Med Pathol"},{"key":"1680_CR74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/6543","volume":"5","author":"C Badorff","year":"1999","unstructured":"Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med. 1999;5:320\u20136.","journal-title":"Nat Med"},{"key":"1680_CR75","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1253\/circj.CJ-16-0234","volume":"80","author":"H Matsuura","year":"2016","unstructured":"Matsuura H, Ichida F, Saji T, Ogawa S, Waki K, Kaneko M, et al. Clinical features of acute and fulminant myocarditis in children- 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circ J. 2016;80:2362\u20138.","journal-title":"Circ J"},{"key":"1680_CR76","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O\u2019Connell J, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841\u20132.","journal-title":"Circulation"},{"key":"1680_CR77","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.jacc.2016.09.937","volume":"68","author":"S Heymans","year":"2016","unstructured":"Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol. 2016;68:2348\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"1680_CR78","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ejhf.767","volume":"19","author":"T Nakayama","year":"2017","unstructured":"Nakayama T, Sugano Y, Yokokawa T, Nagai T, Matsuyama TA, Ohta-Ogo K, et al. Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy. Eur J Heart Fail. 2017;19:490\u20138.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR79","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","volume":"118","author":"I Kindermann","year":"2008","unstructured":"Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118:639\u201348.","journal-title":"Circulation"},{"key":"1680_CR80","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ejhf.1969","volume":"23","author":"G Sinagra","year":"2021","unstructured":"Sinagra G, Porcari A, Gentile P, Artico J, Fabris E, Bussani R, et al. Viral presence-guided immunomodulation in lymphocytic myocarditis: an update. Eur J Heart Fail. 2021;23:211\u20136.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR81","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.118.313578","volume":"124","author":"C Tschope","year":"2019","unstructured":"Tschope C, Cooper LT, Torre-Amione G, Van Linthout S. Management of myocarditis-related cardiomyopathy in adults. Circ Res. 2019;124:1568\u201383.","journal-title":"Circ Res"},{"key":"1680_CR82","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/ejhf.1560","volume":"21","author":"C Tschope","year":"2019","unstructured":"Tschope C, Elsanhoury A, Schlieker S, Van Linthout S, Kuhl U. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence. Eur J Heart Fail. 2019;21:1468\u20139.","journal-title":"Eur J Heart Fail"},{"key":"1680_CR83","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.amjcard.2009.05.041","volume":"104","author":"A Abbate","year":"2009","unstructured":"Abbate A, Sinagra G, Bussani R, Hoke NN, Merlo M, Varma A, et al. Apoptosis in patients with acute myocarditis. Am J Cardiol. 2009;104:995\u20131000.","journal-title":"Am J Cardiol"},{"key":"1680_CR84","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.ijcard.2013.12.137","volume":"171","author":"S Toldo","year":"2014","unstructured":"Toldo S, Kannan H, Bussani R, Anzini M, Sonnino C, Sinagra G, et al. Formation of the inflammasome in acute myocarditis. Int J Cardiol. 2014;171:e119\u201321.","journal-title":"Int J Cardiol"},{"key":"1680_CR85","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1161\/CIRCULATIONAHA.113.003092","volume":"128","author":"M Anzini","year":"2013","unstructured":"Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B, et al. Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation. 2013;128:2384\u201394.","journal-title":"Circulation"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01680-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:28:55Z","timestamp":1744140535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01680-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01680-x","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"10 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"E.D. Adler is a consultant for Abbott, Abiomed, AstraZenica, Endotronix, Ionis, Medtronic, and Novartis, and is on the board of directors of Genstem Therapeutics and shareholder of Rocket Pharmaceuticals. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}